Intrinsiqq
Galenica logo

Galenica Financials

GALE.XSWX

⊜ Compare

All currency values in CHF millions unless otherwise noted

Scroll

Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
RevenueCHF 4,136CHF 3,921CHF 3,746CHF 3,588CHF 3,835
Cost of RevenueCHF 2,980CHF 2,834CHF 2,704CHF 2,603CHF 2,867
Gross ProfitCHF 1,156CHF 1,087CHF 1,042CHF 985CHF 968
Total Operating ExpensesCHF 929CHF 883CHF 852CHF 799CHF 778
Operating IncomeCHF 226CHF 204CHF 190CHF 186CHF 189
Non-Operating
Net Interest Expense-CHF 13-CHF 13-CHF 9-CHF 5-CHF 5
Income Tax ExpenseCHF 38CHF 31CHF 29CHF 32CHF 35
Net Income
Net IncomeCHF 182CHF 184CHF 286CHF 166CHF 168
Per Share Data
Revenue Per ShareCHF 82.97CHF 78.67CHF 75.15CHF 72.15CHF 77.36
EPS (Basic)CHF 3.63CHF 3.67CHF 5.72CHF 3.32CHF 3.38
EPS (Diluted)CHF 3.63CHF 3.67CHF 5.72CHF 3.32CHF 3.38
Shares Outstanding49.8M49.8M49.8M49.7M49.6M
Dividends Per ShareCHF 2.50CHF 2.30CHF 2.20CHF 2.20CHF 2.10

Galenica (GALE.XSWX) financials: revenue, profit and margins

Galenica (GALE.XSWX) generated about CHF 4.1 billion in revenue and CHF 182 million in net income (a 4.4% net margin) over the trailing twelve months, growing at roughly 1.9% a year. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Galenica's (GALE.XSWX) revenue?+

Galenica generated about CHF 4.1 billion in revenue over the trailing twelve months. Revenue has grown at roughly 1.9% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Galenica profitable?+

Yes, Galenica reported about CHF 182 million in net income over the trailing twelve months, a net profit margin of roughly 4.4%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Galenica's profit margins?+

Galenica runs a gross margin of about 27.9%, an operating margin of about 5.5%, a net margin of about 4.4%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Galenica growing?+

Galenica's revenue has compounded at roughly 1.9% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside GALE.XSWX's margins and free cash flow. This is analysis from company filings, not investment advice.

How the market compares: How many US companies are profitable

Peers

Medical Distribution · Pick stocks to compare with GALE.XSWX

CompareIntrinsic value
SOON.XSWXSonova Holding AG
CHF 281.40-0.78%34
STMN.XSWXStraumann
CHF 97.66-0.08%55
LONN.XSWXLonza Group AG
CHF 663.19+1.68%17
SFZN.XSWXSiegfried Holding AG
CHF 75.05+1.42%41
AEVS.XSWXAevis Victoria SA
CHF 14.20-0.35%25
DOCM.XSWXDocMorris AG
CHF 15.94+7.20%26
TECN.XSWXTecan Group AG
CHF 243.00+0.16%35
YPSN.XSWXYpsomed Holding AG
CHF 400.90+1.96%54

Held by ETFs

GALE.XSWX is in 34 US ETFs. The largest of them, with GALE.XSWX's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GALE.XSWX

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.